Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Ambrx Biopharma Inc.’s current trading price is -2.53% away from its 52-week high, while its distance from the 52-week low is 3644.74%. The stock’s price range over this period has fluctuated between $0.38 and $14.60. The company, operating within the financial sector, had a trading volume of approximately 0.71 million for the day, which was noticeably lower than the average daily share volume of 2.76 million over the last 3 months.
The present stock price for Ambrx Biopharma Inc. (AMAM) is $14.23. In the last trading session, the stock made a considerable jump, reaching $15.09 after an opening price of $13.54. The stock briefly fell to $13.54 before ending the session at $13.48.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Ambrx Biopharma Inc. ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $14.60 on 05/23/23, while the lowest value for the same period was recorded at $0.38 on 12/08/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Ambrx Biopharma Inc. (AMAM) has experienced a quarterly rise of 212.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 832.45M and boasts a workforce of 66 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.06, with a change in price of +12.68. Similarly, Ambrx Biopharma Inc. recorded 3,108,581 in trading volume during the last 100 days, posting a change of +818.06%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AMAM stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
AMAM Stock Stochastic Average
Today, Ambrx Biopharma Inc.’s raw stochastic average for the past 50 days stands at 89.07%, indicating a rise from the raw stochastic average of the last 20 days, which was 86.11%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 79.46% and 81.24% respectively.
AMAM Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 526.87% this year. Over the last six months, there has been a weaker performance of 2658.29%. The price of AMAM fallen by 37.62% during the last 30 days period. For the last 5-days stocks have improved 4.63%.
